Avestar Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.84M Buy
4,546
+362
+9% +$147K 0.13% 113
2025
Q1
$2.08M Buy
4,184
+396
+10% +$197K 0.18% 87
2024
Q4
$1.97M Buy
3,788
+590
+18% +$307K 0.17% 87
2024
Q3
$1.98M Buy
3,198
+214
+7% +$132K 0.2% 84
2024
Q2
$1.65M Buy
2,984
+1,052
+54% +$582K 0.17% 93
2024
Q1
$1.12M Buy
1,932
+539
+39% +$313K 0.12% 123
2023
Q4
$740K Buy
1,393
+258
+23% +$137K 0.08% 134
2023
Q3
$575K Buy
1,135
+153
+16% +$77.4K 0.08% 139
2023
Q2
$512K Buy
982
+30
+3% +$15.7K 0.08% 130
2023
Q1
$549K Buy
952
+62
+7% +$35.8K 0.1% 123
2022
Q4
$490K Sell
890
-56
-6% -$30.8K 0.09% 128
2022
Q3
$480K Buy
946
+114
+14% +$57.8K 0.12% 113
2022
Q2
$452K Buy
832
+9
+1% +$4.89K 0.11% 113
2022
Q1
$486K Buy
823
+170
+26% +$100K 0.08% 199
2021
Q4
$436K Sell
653
-34
-5% -$22.7K 0.05% 216
2021
Q3
$393K Sell
687
-13
-2% -$7.44K 0.05% 229
2021
Q2
$353K Buy
700
+20
+3% +$10.1K 0.05% 233
2021
Q1
$330K Buy
680
+21
+3% +$10.2K 0.07% 232
2020
Q4
$307K Buy
659
+38
+6% +$17.7K 0.09% 207
2020
Q3
$300K Sell
621
-99
-14% -$47.8K 0.1% 162
2020
Q2
$261K Sell
720
-46
-6% -$16.7K 0.12% 148
2020
Q1
$217K Buy
766
+24
+3% +$6.8K 0.12% 145
2019
Q4
$241K Sell
742
-2
-0.3% -$650 0.14% 136
2019
Q3
$217K Buy
744
+231
+45% +$67.4K 0.13% 145
2019
Q2
$130K Sell
513
-56
-10% -$14.2K 0.08% 155
2019
Q1
$134K Sell
569
-71
-11% -$16.7K 0.09% 156
2018
Q4
$125K Sell
640
-79
-11% -$15.4K 0.09% 146
2018
Q3
$152K Buy
719
+48
+7% +$10.1K 0.09% 147
2018
Q2
$115K Buy
671
+36
+6% +$6.17K 0.07% 184
2018
Q1
$110K Buy
635
+63
+11% +$10.9K 0.07% 162
2017
Q4
$93K Buy
+572
New +$93K 0.07% 164